Healthcare companies headquartered in Canada have experienced a substantial drop in venture funding this year, with total capital invested falling to $67 million from last year's $165 million. Deal count has fallen as well—albeit not nearly as dramatically as capital—and currently stands at 13 financings in 2012, down from 21 in 2011. In addition to decreases in deal count and total capital invested between 2011 and 2012, the relatively dismal activity is also reflected in the median deal size. Last year's median deal stood at $7 million, while this year's has plunged to $2.1 million. Smaller financings like Drop of Genius Microsystems' recent $2.7 million have become more of a norm this year, but December deal-making could very well quicken its pace and boost that number.